Methylprednisolone succinate

Methylprednisolone sodium succinate is an injectable corticosteroid used for its potent anti-inflammatory and immunosuppressive effects in treating a wide range of conditions when oral therapy is not an option. It is grouped under the following drug class(es): Steroids. Its therapeutic use is listed as antirheumatic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include 6a-Methylprednisolone 21-Hemisuccinate and Urbasonsoluble. Its PubChem CID is 16923.

CAS No 2921-57-5
Molecular Formula C26H34O8
Molecular Weight 474.50 g/mol
Synonyms 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid

Frequently Asked Questions